Literature DB >> 25766456

Feedback for patients reporting adverse drug reactions; satisfaction and expectations.

Leàn Rolfes1, Florence van Hunsel, Kees van Grootheest, Eugène van Puijenbroek.   

Abstract

OBJECTIVE: Due to the rising number of patient reports in pharmacovigilance, the manner in which feedback is provided to patients is an element to be considered. The objective is to explore the satisfaction of patients towards personalized and general feedback in response to their reported adverse drug reactions (ADRs).
METHODS: Patients who reported an ADR to the Dutch Pharmacovigilance Centre for the first time in the period between October 2012 and April 2013 were included. Reporters received personalized feedback or a general acknowledgement letter. Satisfaction towards the received feedback, expressed on a 5-point Likert scale (1 very good to 5 very poor), was studied using a web-based questionnaire. Data were analyzed using Pearson Chi-square test and linear regression analysis. Statistical significance was based on p < 0.05.
RESULTS: A total of 471 patient-reporters were contacted with a total response of 52.5%. Respondents of both groups were satisfied with the received feedback, average score 2 (good). Respondents of the personalized feedback-group were however more satisfied score 2.0 versus 2.5 (p < 0.001) and considered the feedback more clear and useful compared with respondents of the acknowledgement letter-group, respectively score 1.6 versus 1.7 (p = 0.01) and score 2.1 versus 2.5 (p < 0.001).
CONCLUSION: Patients reporting ADRs are satisfied with feedback received from the pharmacovigilance centre, whether this is a personalized feedback or a general acknowledgment letter. They find it clear, useful and it meets their expectation. Although differences were found between the two types of feedback, these differences did not indicate dissatisfaction towards the received feedback.

Entities:  

Keywords:  adverse drug reactions; feedback; patient reporting; pharmacovigilance

Mesh:

Year:  2015        PMID: 25766456     DOI: 10.1517/14740338.2015.1021775

Source DB:  PubMed          Journal:  Expert Opin Drug Saf        ISSN: 1474-0338            Impact factor:   4.250


  7 in total

1.  A Qualitative Study of Stakeholders' Views on Pharmacovigilance System, Policy, and Coordination in Pakistan.

Authors:  Muhammad Akhtar Abbas Khan; Saima Hamid; Shahzad Ali Khan; Mariyam Sarfraz; Zaheer-Ud-Din Babar
Journal:  Front Pharmacol       Date:  2022-06-09       Impact factor: 5.988

2.  The Impact of Experiencing Adverse Drug Reactions on the Patient's Quality of Life: A Retrospective Cross-Sectional Study in the Netherlands.

Authors:  Leàn Rolfes; Florence van Hunsel; Katja Taxis; Eugène van Puijenbroek
Journal:  Drug Saf       Date:  2016-08       Impact factor: 5.606

3.  The Quality of Clinical Information in Adverse Drug Reaction Reports by Patients and Healthcare Professionals: A Retrospective Comparative Analysis.

Authors:  Leàn Rolfes; Florence van Hunsel; Laura van der Linden; Katja Taxis; Eugène van Puijenbroek
Journal:  Drug Saf       Date:  2017-07       Impact factor: 5.606

4.  Dedicated mobile application for drug adverse reaction reporting by patients with relapsing remitting multiple sclerosis (Vigip-SEP study): study protocol for a randomized controlled trial.

Authors:  Gilles Defer; Florian Le Caignec; Sophie Fedrizzi; François Montastruc; Damien Chevanne; Jean-Jacques Parienti; Laure Peyro-Saint-Paul
Journal:  Trials       Date:  2018-03-09       Impact factor: 2.279

5.  Recommendations on the Use of Mobile Applications for the Collection and Communication of Pharmaceutical Product Safety Information: Lessons from IMI WEB-RADR.

Authors:  Carrie E Pierce; Sieta T de Vries; Stephanie Bodin-Parssinen; Linda Härmark; Phil Tregunno; David J Lewis; Simon Maskell; Raphael Van Eemeren; Alicia Ptaszynska-Neophytou; Victoria Newbould; Nabarun Dasgupta; Antoni F Z Wisniewski; Sara Gama; Peter G M Mol
Journal:  Drug Saf       Date:  2019-04       Impact factor: 5.606

Review 6.  The Importance of Direct Patient Reporting of Adverse Drug Reactions in the Safety Monitoring Process.

Authors:  Kamila Sienkiewicz; Monika Burzyńska; Izabela Rydlewska-Liszkowska; Jacek Sienkiewicz; Ewelina Gaszyńska
Journal:  Int J Environ Res Public Health       Date:  2021-12-31       Impact factor: 3.390

Review 7.  Comparison of Patient Adverse Drug Reaction Reporting Systems in Nine Selected Countries.

Authors:  Wiwan Worakunphanich; Sitaporn Youngkong; Wimon Suwankesawong; Claire Anderson; Montarat Thavorncharoensap
Journal:  Int J Environ Res Public Health       Date:  2022-04-07       Impact factor: 3.390

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.